155 related articles for article (PubMed ID: 28260052)
21. The kinase LMTK3 promotes invasion in breast cancer through GRB2-mediated induction of integrin β₁.
Xu Y; Zhang H; Lit LC; Grothey A; Athanasiadou M; Kiritsi M; Lombardo Y; Frampton AE; Green AR; Ellis IO; Ali S; Lenz HJ; Thanou M; Stebbing J; Giamas G
Sci Signal; 2014 Jun; 7(330):ra58. PubMed ID: 24939894
[TBL] [Abstract][Full Text] [Related]
22. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF.
Jia W; Gao XJ; Zhang ZD; Yang ZX; Zhang G
Eur Rev Med Pharmacol Sci; 2013 Jun; 17(11):1495-508. PubMed ID: 23771538
[TBL] [Abstract][Full Text] [Related]
23. [Effects of genistein on proliferation and invasion of human thyroid squamous cell carcinoma SW579 cells].
Zhao D; Yin J; Wu S; Wu Z; Pan H
Wei Sheng Yan Jiu; 2018 Nov; 47(6):984-992. PubMed ID: 30593333
[TBL] [Abstract][Full Text] [Related]
24. Contactin 1 as a potential biomarker promotes cell proliferation and invasion in thyroid cancer.
Shi K; Xu D; Yang C; Wang L; Pan W; Zheng C; Fan L
Int J Clin Exp Pathol; 2015; 8(10):12473-81. PubMed ID: 26722434
[TBL] [Abstract][Full Text] [Related]
25. The role of TAK1 expression in thyroid cancer.
Lin P; Niu W; Peng C; Zhang Z; Niu J
Int J Clin Exp Pathol; 2015; 8(11):14449-56. PubMed ID: 26823762
[TBL] [Abstract][Full Text] [Related]
26. PFTK1 Promotes Gastric Cancer Progression by Regulating Proliferation, Migration and Invasion.
Yang L; Zhu J; Huang H; Yang Q; Cai J; Wang Q; Zhu J; Shao M; Xiao J; Cao J; Gu X; Zhang S; Wang Y
PLoS One; 2015; 10(10):e0140451. PubMed ID: 26488471
[TBL] [Abstract][Full Text] [Related]
27. IQGAP1 modulates the proliferation and invasion of thyroid cancer cells in response to estrogen.
Meng D; Wu W; Li Z; Qin G
Int J Mol Med; 2015 Aug; 36(2):588-94. PubMed ID: 26046126
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of Notch-regulated Ankyrin Repeat Protein Exerts Antitumor Activities against Growth of Thyroid Cancer.
Chu BF; Qin YY; Zhang SL; Quan ZW; Zhang MD; Bi JW
Chin Med J (Engl); 2016 Jul; 129(13):1544-52. PubMed ID: 27364790
[TBL] [Abstract][Full Text] [Related]
29. BTG1 expression in thyroid carcinoma: diagnostic indicator and prognostic marker.
Lu YF; Sun GG; Liu Q; Yang CR; Cheng YJ
Int J Oncol; 2014 Oct; 45(4):1574-82. PubMed ID: 25017022
[TBL] [Abstract][Full Text] [Related]
30. TGF-β1 induces HMGA1 expression: The role of HMGA1 in thyroid cancer proliferation and invasion.
Zhong J; Liu C; Zhang QH; Chen L; Shen YY; Chen YJ; Zeng X; Zu XY; Cao RX
Int J Oncol; 2017 May; 50(5):1567-1578. PubMed ID: 28393241
[TBL] [Abstract][Full Text] [Related]
31. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.
Chou CK; Yang KD; Chou FF; Huang CC; Lan YW; Lee YF; Kang HY; Liu RT
J Clin Endocrinol Metab; 2013 Feb; 98(2):E196-205. PubMed ID: 23264400
[TBL] [Abstract][Full Text] [Related]
32. LRG‑1 enhances the migration of thyroid carcinoma cells through promotion of the epithelial‑mesenchymal transition by activating MAPK/p38 signaling.
Ban Z; He J; Tang Z; Zhang L; Xu Z
Oncol Rep; 2019 Jun; 41(6):3270-3280. PubMed ID: 31002347
[TBL] [Abstract][Full Text] [Related]
33. LMTK3 confers chemo-resistance in breast cancer.
Stebbing J; Shah K; Lit LC; Gagliano T; Ditsiou A; Wang T; Wendler F; Simon T; Szabó KS; O'Hanlon T; Dean M; Roslani AC; Cheah SH; Lee SC; Giamas G
Oncogene; 2018 Jun; 37(23):3113-3130. PubMed ID: 29540829
[TBL] [Abstract][Full Text] [Related]
34. Aberrant overexpression of pyruvate kinase M2 is associated with aggressive tumor features and the BRAF mutation in papillary thyroid cancer.
Feng C; Gao Y; Wang C; Yu X; Zhang W; Guan H; Shan Z; Teng W
J Clin Endocrinol Metab; 2013 Sep; 98(9):E1524-33. PubMed ID: 23846818
[TBL] [Abstract][Full Text] [Related]
35. LRP4 promotes proliferation, migration, and invasion in papillary thyroid cancer.
Zhou X; Xia E; Bhandari A; Zheng C; Xiang J; Guan Y; Zhang X
Biochem Biophys Res Commun; 2018 Sep; 503(1):257-263. PubMed ID: 29885843
[TBL] [Abstract][Full Text] [Related]
36. TRIM29 promotes progression of thyroid carcinoma via activating P13K/AKT signaling pathway.
Xu J; Li Z; Su Q; Zhao J; Ma J
Oncol Rep; 2017 Mar; 37(3):1555-1564. PubMed ID: 28098872
[TBL] [Abstract][Full Text] [Related]
37. Serum lemur tyrosine kinase 3 expression in colorectal cancer patients predicts cancer progression and prognosis.
Shi H; Wu J; Ji M; Zhou Q; Li Z; Zheng X; Xu B; Deng H; Zhao W; Wu C; Jiang J
Med Oncol; 2013 Dec; 30(4):754. PubMed ID: 24174317
[TBL] [Abstract][Full Text] [Related]
38. KITENIN is associated with tumor progression in human gastric cancer.
Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE
Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126
[TBL] [Abstract][Full Text] [Related]
39. Expression of early growth response-1 in colorectal cancer and its relation to tumor cell proliferation and apoptosis.
Myung DS; Park YL; Kim N; Chung CY; Park HC; Kim JS; Cho SB; Lee WS; Lee JH; Joo YE
Oncol Rep; 2014 Feb; 31(2):788-94. PubMed ID: 24297681
[TBL] [Abstract][Full Text] [Related]
40. Histone deacetylase enzyme silencing using shRNAs enhances radiosensitivity of SW579 thyroid cancer cells.
Wang Y; Jin T; Dai X; Yan D; Peng Z
Mol Med Rep; 2016 Oct; 14(4):3509-16. PubMed ID: 27600599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
